Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Comparative Evaluation of ChatGPT and Gemini in Answering Questions on Vaccines and Immunization
0
Zitationen
3
Autoren
2025
Jahr
Abstract
Background/Aims: This study aimed to evaluate and compare the adequacy, reliability, and reproducibility of ChatGPT-4 Plus and Gemini Advanced chatbots in answering questions about vaccines and immunization. Given the growing role of artificial intelligence in healthcare communication, evaluating the performance of these models is crucial for their effective integration into public health strategies. Methods: A total of 56 questions were selected from World Health Organization educational materials and a national guideline on adult vaccination. Questions were categorized into four domains: Myths and Misconceptions, Vaccination and Immunization, Basic Principles of Vaccination, and Claims and Facts about Vaccines. Two infectious disease specialists independently rated chatbot responses using the Global Quality Score (1–5). Discrepancies were resolved by a third evaluator. Inter-rater reliability, reproducibility, and correlation of responses were also assessed. Results: ChatGPT-4 Plus received a perfect score (5 points) in 83.9% of responses, while Gemini achieved this in 71.4% of responses. Mean scores were similar (4.70±0.72 vs. 4.61±0.75, p=0.116). ChatGPT-4 Plus outperformed Gemini in the "Claims and Facts" category (p=0.012), while other categories showed no significant differences. Both models demonstrated substantial inter-rater agreement (κ=0.540 for ChatGPT, κ=0.572 for Gemini) and moderate correlation (r=0.521, p
Ähnliche Arbeiten
Vaccine hesitancy: Definition, scope and determinants
2015 · 5.497 Zit.
Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey
2020 · 3.246 Zit.
A global survey of potential acceptance of a COVID-19 vaccine
2020 · 3.028 Zit.
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
2021 · 2.782 Zit.
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
2020 · 2.701 Zit.